FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Haddow

Research Profile

Physiology

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Phenomena

False Positive Reactions

Geographic Areas

Maine

Co-author Network

Publications

TOP 3
Jacob A Canick; Cosmin Deciu; Mathias Ehrich; James E Haddow; Edward M Kloza; Geralyn M Lambert-Messerlian; Allan T Bombard; Dirk van den Boom; Glenn E Palomaki
DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.
Glenn E Palomaki; Dirk van den Boom; Allan T Bombard; Cosmin Deciu; Mathias Ehrich; Wayne W Grody; James E Haddow; Edward M Kloza; Geralyn M Lambert-Messerlian; Stanley F Nelson; Louis M Neveux; Jacob A Canick
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.
Wendy Y Craig; Glenn Palomaki; Marie Roberson; James E Haddow
Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Haddow (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jacob A Canick; Cosmin Deciu; Mathias Ehrich; James E Haddow; Edward M Kloza; Geralyn M Lambert-Messerlian; Allan T Bombard; Dirk van den Boom; Glenn E Palomaki
DNA sequencing of maternal plasma to identify Down syndrome and other trisomies in multiple gestations.
Prenatal diagnosis 2012;32(8):730-4.
2012: Glenn E Palomaki; Dirk van den Boom; Allan T Bombard; Cosmin Deciu; Mathias Ehrich; Wayne W Grody; James E Haddow; Edward M Kloza; Geralyn M Lambert-Messerlian; Stanley F Nelson; Louis M Neveux; Jacob A Canick
DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study.
Genetics in medicine : official journal of the American College of Medical Genetics 2012;14(3):296-305.
2011: Wendy Y Craig; Glenn Palomaki; Marie Roberson; James E Haddow
Further insights into implications of undetectable or very low unconjugated estriol in maternal serum during the second trimester.
Prenatal diagnosis 2011;31(6):616-8.
2011: James E Haddow; Monica R McClain; Glenn E Palomaki; Louis M Neveux; Geralyn M Lambert-Messerlian; Jacob A Canick; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and placental abruption.
Obstetrics and gynecology 2011;117(2 Pt 1):287-92.
2010: Wendy Y Craig; Marie Roberson; Glenn E Palomaki; Cedric H L Shackleton; Josep Marcos del Aguila; James E Haddow
Prevalence of steroid sulfatase deficiency in California according to race and ethnicity.
Prenatal diagnosis 2010;30(9):893-8.
2010: James E Haddow; Jane Cleary-Goldman; Monica R McClain; Glenn E Palomaki; Louis M Neveux; Geralyn M Lambert-Messerlian; Jacob A Canick; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Thyroperoxidase and thyroglobulin antibodies in early pregnancy and preterm delivery.
Obstetrics and gynecology 2010;116(1):58-62.
2009: Josep Marcos del Aguila; Wendy Y Craig; Glenn E Palomaki; Edward M Kloza; James E Haddow; Marie Roberson; Linda A Bradley; Cedric H L Shackleton
Maternal urine and serum steroid measurements to identify steroid sulfatase deficiency (STSD) in second trimester pregnancies.
Prenatal diagnosis 2009;29(8):771-80.
2008: James E Haddow; Monica R McClain; Geralyn M Lambert-Messerlian; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy.
The Journal of clinical endocrinology and metabolism 2008;93(9):3341-7.
2008: Monica R McClain; Geralyn M Lambert-Messerlian; James E Haddow; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
Sequential first- and second-trimester TSH, free thyroxine, and thyroid antibody measurements in women with known hypothyroidism: a FaSTER trial study.
American journal of obstetrics and gynecology 2008;199(2):129.e1-6.
2008: Geralyn M Lambert-Messerlian; Monica McClain; James E Haddow; Glenn E Palomaki; Jacob A Canick; Jane Cleary-Goldman; Fergal D Malone; T Flint Porter; David A Nyberg; Peter S Bernstein; Mary E D'alton
First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study.
American journal of obstetrics and gynecology 2008;199(1):62.e1-6.
2008: Glenn E Palomaki; Louis M Neveux; Alan Donnenfeld; Jo Ellen S Lee; Geraldine McDowell; Jacob A Canick; Anne Summers; Geralyn M Lambert-Messerlian; Leonard H Kellner; Arthur Zebelman; James E Haddow
Quality assessment of routine nuchal translucency measurements: a North American laboratory perspective.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):131-8.
2008: Monica R McClain; Glenn E Palomaki; Margaret Piper; James E Haddow
A rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding.
Genetics in medicine : official journal of the American College of Medical Genetics 2008;10(2):89-98.
2008: Monica R McClain; Glenn E Palomaki; Heather Hampel; Judith A Westman; James E Haddow
Screen positive rates among six family history screening protocols for breast/ovarian cancer in four cohorts of women.
Familial cancer 2008;7(4):341-5.
2007: Joseph G Hollowell; James E Haddow
The prevalence of iodine deficiency in women of reproductive age in the United States of America.
Public health nutrition 2007;10(12A):1532-9; discussion 1540-1.
2007: Cedric H L Shackleton; Josep Marcos del Aguila; Glenn E Palomaki; Wendy Y Craig; Richard I Kelley; Lisa Kratz; James E Haddow
Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS).
American journal of medical genetics. Part A 2007;143A(18):2129-36.
2007: Glenn E Palomaki; Louis M Neveux; James E Haddow; Philip Wyatt
Hyperglycosylated-hCG (h-hCG) and Down syndrome screening in the first and second trimesters of pregnancy.
Prenatal diagnosis 2007;27(9):808-13.
2007: Glenn E Palomaki; Louis M Neveux; George J Knight; James E Haddow; JoEllen Lee
Estimating first-trimester combined screening performance for Down syndrome in dried blood spots versus fresh sera.
Genetics in medicine : official journal of the American College of Medical Genetics 2007;9(7):458-63.
2007: Wendy Y Craig; James E Haddow; Glenn E Palomaki; Marie Roberson
Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
Prenatal diagnosis 2007;27(5):409-14.
2007: Linda A Bradley; Edward M Kloza; Paula K Haddow; Laurent J Beauregard; Judith L Johnson; James E Haddow
A genetic history questionnaire-based system in primary prenatal care to screen for selected fetal disorders.
Genetic testing 2007;11(3):291-5.
2006: Wendy Y Craig; James E Haddow; Glenn E Palomaki; Richard I Kelley; Lisa Kratz; Cedric H L Shackleton; Josep Marcos del Aguila; G Stephen Tint; Andrew R MacRae; Malgorzata J M Nowaczyk; Edward M Kloza; Mira Irons; Marie Roberson
Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome.
Prenatal diagnosis 2006;26(9):842-9.
2006: Glenn E Palomaki; Dave Wright; Anne M Summers; Louis M Neveux; Christian Meier; Andrea O'Donnell; Tianhua Huang; George J Knight; James E Haddow
Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
Prenatal diagnosis 2006;26(8):730-9.
2006: Glenn E Palomaki; Monica R McClain; Klaus Steinort; Randa Sifri; Leigh LoPresti; James E Haddow
Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women.
Genetics in medicine : official journal of the American College of Medical Genetics 2006;8(3):161-8.
2006: James E Haddow; Monica R McClain; Glenn E Palomaki; Edward M Kloza; Josephine Williams
Screening for thyroid disorders during pregnancy: results of a survey in Maine.
American journal of obstetrics and gynecology 2006;194(2):471-4.
2006: Glenn E Palomaki; Klaus Steinort; George J Knight; James E Haddow
Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
Obstetrics and gynecology 2006;107(2 Pt 1):367-75.
2005: George J Knight; Glenn E Palomaki; Louis M Neveux; Dwight E Smith; Edward M Kloza; Andrea J Pulkkinen; Josephine Williams; James E Haddow
Integrated serum screening for Down syndrome in primary obstetric practice.
Prenatal diagnosis 2005;25(12):1162-7.
2005: Glenn E Palomaki; Edward M Kloza; James E Haddow; Josephine Williams; George J Knight
Patient and health professional acceptance of integrated serum screening for Down syndrome.
Seminars in perinatology 2005;29(4):247-51.
2005: Glenn E Palomaki; George J Knight; Louis M Neveux; Raj Pandian; James E Haddow
Maternal serum invasive trophoblast antigen and first-trimester Down syndrome screening.
Clinical chemistry 2005;51(8):1499-504.
2005: Monica R McClain; Katherine L Nathanson; Glenn E Palomaki; James E Haddow
An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):34-9.
2005: Monica R McClain; Glenn E Palomaki; Katherine L Nathanson; James E Haddow
Adjusting the estimated proportion of breast cancer cases associated with BRCA1 and BRCA2 mutations: public health implications.
Genetics in medicine : official journal of the American College of Medical Genetics 2005;7(1):28-33.
2004: Glenn E Palomaki; Louis M Neveux; George J Knight; James E Haddow; Raj Pandian
Maternal serum invasive trophoblast antigen (hyperglycosylated hCG) as a screening marker for Down syndrome during the second trimester.
Clinical chemistry 2004;50(10):1804-8.
2004: Glenn E Palomaki; Stacey C FitzSimmons; James E Haddow
Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.
Genetics in medicine : official journal of the American College of Medical Genetics 2004;6(5):405-14.
2004: James E Haddow; George J Knight; Glenn E Palomaki; M R McClain; A J Pulkkinen
The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy.
Journal of medical screening 2004;11(4):170-4.
2003: Glenn E Palomaki; James E Haddow; Linda A Bradley; Carolyn S (Sue) Richards; Timothy T Stenzel; Wayne W Grody
Estimated analytic validity of HFE C282Y mutation testing in population screening: the potential value of confirmatory testing.
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(6):440-3.
2003: Carolyn S (Sue) Richards; James E Haddow
Prenatal screening for cystic fibrosis.
Clinics in laboratory medicine 2003;23(2):503-30, x-xi.
2003: Glenn E Palomaki; Louis M Neveux; George J Knight; James E Haddow
Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers.
Prenatal diagnosis 2003;23(3):243-7.
2003: Glenn E Palomaki; Linda A Bradley; Carolyn S (Sue) Richards; James E Haddow
Analytic validity of cystic fibrosis testing: a preliminary estimate.
Genetics in medicine : official journal of the American College of Medical Genetics 2003;5(1):15-20.
2002: Nicholas J Wald; Malcolm Law; James E Haddow; Wendy Y Craig
Apolipoprotiens and prediction of fatal myocardial infarction.
Lancet 2002;359(9320):1864.
2002: Glenn E Palomaki; James E Haddow; Linda A Bradley; Stacey C FitzSimmons
Updated assessment of cystic fibrosis mutation frequencies in non-Hispanic Caucasians.
Genetics in medicine : official journal of the American College of Medical Genetics 2002;4(2):90-4.
2002: Glenn E Palomaki; Linda A Bradley; George J Knight; Wendy Y Craig; James E Haddow
Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndrome.
Journal of medical screening 2002;9(1):43-4.
2001: Walter C Allan; Katherine W Timothy; G Michael Vincent; Glenn E Palomaki; Louis M Neveux; James E Haddow
Long QT syndrome in children: the value of the rate corrected QT interval in children who present with fainting.
Journal of medical screening 2001;8(4):178-82.
2001: Walter C Allan; Katherine W Timothy; G Michael Vincent; Glenn E Palomaki; Louis M Neveux; James E Haddow
Long QT syndrome in children: the value of rate corrected QT interval and DNA analysis as screening tests in the general population.
Journal of medical screening 2001;8(4):173-7.
2001: George J Knight; Glenn E Palomaki; Louis M Neveux; James E Haddow; Geralyn M Lambert-Messerlian
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
Journal of medical screening 2001;8(1):2-7.
2001: RZ Klein; James D Sargent; P. Reed larsen; SE Waisbren; James E Haddow; Marvin L Mitchell
Relation of severity of maternal hypothyroidism to cognitive development of offspring.
Journal of medical screening 2001;8(1):18-20.
2000: Marvin L Mitchell; Rosalie J Hermos; Cecilia A Larson; Glenn E Palomaki; James E Haddow
Prevalence of GAD autoantibodies in women with gestational diabetes: a retrospective analysis.
Diabetes care 2000;23(11):1705-6.
2000: Walter C Allan; James E Haddow; Glenn E Palomaki; J R Williams; Marvin L Mitchell; Rosalie J Hermos; JD Faix; RZ Klein
Maternal thyroid deficiency and pregnancy complications: implications for population screening.
Journal of medical screening 2000;7(3):127-30.
1999: James E Haddow; Glenn E Palomaki; Walter C Allan; J R Williams; George J Knight; J Gagnon; C E O'Heir; Marvin L Mitchell; Rosalie J Hermos; SE Waisbren; JD Faix; RZ Klein
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child.
The New England journal of medicine 1999;341(8):549-55.
1999: Linda A Bradley; Glenn E Palomaki; George J Knight; James E Haddow; J M Opitz; Mira Irons; Richard I Kelley; Stephen G Tint
Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses.
American journal of medical genetics 1999;82(4):355-8.
1999: James E Haddow; Linda A Bradley; Glenn E Palomaki; RA Doherty
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.
Journal of medical screening 1999;6(2):60-6.
1998: Hilary C Watt; Malcolm Law; Nicholas J Wald; Wendy Y Craig; Thomas B Ledue; James E Haddow
Serum triglyceride: a possible risk factor for ruptured abdominal aortic aneurysm.
International journal of epidemiology 1998;27(6):949-52.
1998: Wendy Y Craig; Louis M Neveux; Glenn E Palomaki; M M Cleveland; James E Haddow
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies.
Clinical chemistry 1998;44(11):2301-6.
1998: James E Haddow
Antenatal screening for Down's syndrome: where are we and where next?
Lancet 1998;352(9125):336-7.
1998: James E Haddow; Glenn E Palomaki; George J Knight; Josephine Williams; W A Miller; Anthony Johnson
Screening of maternal serum for fetal Down's syndrome in the first trimester.
The New England journal of medicine 1998;338(14):955-61.
1998: Nicholas J Wald; HC Watt; James E Haddow; George J Knight
Screening for Down syndrome at 14 weeks of pregnancy.
Prenatal diagnosis 1998;18(3):291-3.
1998: George J Knight; Glenn E Palomaki; Louis M Neveux; K K Fodor; James E Haddow
hCG and the free beta-subunit as screening tests for Down syndrome.
Prenatal diagnosis 1998;18(3):235-45.
1998: James E Haddow; Glenn E Palomaki; George J Knight; D L Foster; Louis M Neveux
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Journal of medical screening 1998;5(3):115-9.
1998: Linda A Bradley; D D Johnson; Glenn E Palomaki; James E Haddow; N H Robertson; RM Ferrie
Hereditary haemochromatosis mutation frequencies in the general population.
Journal of medical screening 1998;5(1):34-6.
1997: Glenn E Palomaki; George J Knight; J E McCarthy; James E Haddow; J M donhowe
Maternal serum screening for Down syndrome in the United States: a 1995 survey.
American journal of obstetrics and gynecology 1997;176(5):1046-51.
1997: Linda A Bradley; J A Canick; Glenn E Palomaki; James E Haddow
Undetectable maternal serum unconjugated estriol levels in the second trimester: risk of perinatal complications associated with placental sulfatase deficiency.
American journal of obstetrics and gynecology 1997;176(3):531-5.
1997: RA Doherty; Linda A Bradley; James E Haddow
Prenatal screening for cystic fibrosis: an updated perspective.
American journal of obstetrics and gynecology 1997;176(2):268-70.
1996: Louis M Neveux; Glenn E Palomaki; D A Larrivee; George J Knight; James E Haddow
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Prenatal diagnosis 1996;16(12):1115-9.
1996: James E Haddow; Glenn E Palomaki; George J Knight; J Williams; B A Chilmonczyk
Intervening to reduce environmental tobacco smoke exposure in infants.
Pediatrics 1996;98(3 Pt 1):513.
1996: R A Doherty; Glenn E Palomaki; E M Kloza; J L Erickson; James E Haddow
Couple-based prenatal screening for cystic fibrosis in primary care settings.
Prenatal diagnosis 1996;16(5):397-404.
1996: Linda A Bradley; James E Haddow; Glenn E Palomaki
Population screening for haemochromatosis: a unifying analysis of published intervention trials.
Journal of medical screening 1996;3(4):178-84.
1996: Linda A Bradley; James E Haddow; Glenn E Palomaki
Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands.
Journal of medical screening 1996;3(4):171-7.
1996: Glenn E Palomaki; Louis M Neveux; James E Haddow
Can reliable Down's syndrome detection rates be determined from prenatal screening intervention trials?
Journal of medical screening 1996;3(1):12-7.
1996: Louis M Neveux; Glenn E Palomaki; George J Knight; James E Haddow
Multiple marker screening for Down syndrome in twin pregnancies.
Prenatal diagnosis 1996;16(1):29-34.
1995: Nicholas J Wald; A Kennard; H Watt; James E Haddow; Glenn E Palomaki; G Knight; J A Canick
Decision analysis and screening for Down's syndrome. Testing should be in all women.
BMJ (Clinical research ed.) 1995;311(7016):1372-3.
1995: Glenn E Palomaki; James E Haddow; George J Knight; Nicholas J Wald; A Kennard; Jacob A Canick; Devereux N Saller; Miriam G Blitzer; L H Dickerman; R Fisher
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin.
Prenatal diagnosis 1995;15(8):713-23.
1995: James E Haddow; Glenn E Palomaki; George J Knight
Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening.
Journal of medical screening 1995;2(1):28-30.
1994: James E Haddow; Glenn E Palomaki; George J Knight; George C Cunningham; L S Lustig; P A Boyd
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
The New England journal of medicine 1994;330(16):1114-8.
1994: Glenn E Palomaki; Linda A Bradley; James E Haddow
A new approach to analysing fluorescence in situ hybridisation data for rapid detection of aneuploidy in amniocytes.
Journal of medical screening 1994;1(2):96-7.
1994: James E Haddow; George J Knight; Glenn E Palomaki; Louis M Neveux; B A Chilmonczyk
Replacing creatinine measurements with specific gravity values to adjust urine cotinine concentrations.
Clinical chemistry 1994;40(4):562-4.
1994: NC Rose; Glenn E Palomaki; James E Haddow; D B Goodman; Michael T Mennuti
Maternal serum alpha-fetoprotein screening for chromosomal abnormalities: a prospective study in women aged 35 and older.
American journal of obstetrics and gynecology 1994;170(4):1073-8; discussion 1078-80.
1994: R A Doherty; Glenn E Palomaki; E M Kloza; J L Erickson; D A Dostal; James E Haddow
Prenatal screening for cystic fibrosis.
Lancet 1994;343(8890):172.
1994: James E Haddow; Thomas B Ledue
Preventing manifestations of hereditary haemochromatosis through population based screening.
Journal of medical screening 1994;1(1):16-21.
1994: Glenn E Palomaki; George J Knight; James E Haddow
Human chorionic gonadotropin and unconjugated oestriol measurements in insulin-dependent diabetic pregnant women being screened for fetal Down syndrome.
Prenatal diagnosis 1994;14(1):65-8.
1993: Glenn E Palomaki; George J Knight; J McCarthy; James E Haddow; J H Eckfeldt
Maternal serum screening for fetal Down syndrome in the United States: a 1992 survey.
American journal of obstetrics and gynecology 1993;169(6):1558-62.
1993: B A Chilmonczyk; L M Salmun; K N Megathlin; Louis M Neveux; Glenn E Palomaki; George J Knight; A J Pulkkinen; James E Haddow
Association between exposure to environmental tobacco smoke and exacerbations of asthma in children.
The New England journal of medicine 1993;328(23):1665-9.
1993: Glenn E Palomaki; George J Knight; James E Haddow; Jacob A Canick; Nicholas J Wald; A Kennard
Cigarette smoking and levels of maternal serum alpha-fetoprotein, unconjugated estriol, and hCG: impact on Down syndrome screening.
Obstetrics and gynecology 1993;81(5 ( Pt 1)):675-8.
1993: James E Haddow; Glenn E Palomaki; M S Holman
Young maternal age and smoking during pregnancy as risk factors for gastroschisis.
Teratology 1993;47(3):225-8.
1993: AE Donnenfeld; A Pulkkinen; Glenn E Palomaki; George J Knight; James E Haddow
Simultaneous fetal and maternal cotinine levels in pregnant women smokers.
American journal of obstetrics and gynecology 1993;168(3 Pt 1):781-2.
1992: Glenn E Palomaki; George J Knight; James E Haddow; Jacob A Canick; Devereux N Saller; D S Panizza
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin.
Prenatal diagnosis 1992;12(11):925-30.
1992: James E Haddow; Glenn E Palomaki; George J Knight; J Williams; A Pulkkinen; Jacob A Canick; Devereux N Saller; G B Bowers
Prenatal screening for Down's syndrome with use of maternal serum markers.
The New England journal of medicine 1992;327(9):588-93.
1992: B A Chilmonczyk; Glenn E Palomaki; George J Knight; J Williams; James E Haddow
An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy.
American journal of diseases of children (1960) 1992;146(3):357-60.
1992: James E Haddow; M S Holman; Glenn E Palomaki
Can gestational dates routinely derived from very early ultrasound be used to interpret maternal serum alpha-fetoprotein measurements?
Prenatal diagnosis 1992;12(1):65-8.
1991: NC Rose; James E Haddow; Glenn E Palomaki; George J Knight
Self-rated physical activity level during the second trimester and pregnancy outcome.
Obstetrics and gynecology 1991;78(6):1078-80.
1991: James E Haddow; N S Rote; D Dostal-Johnson; Glenn E Palomaki; A J Pulkkinen; George J Knight
Lack of an association between late fetal death and antiphospholipid antibody measurements in the second trimester.
American journal of obstetrics and gynecology 1991;165(5 Pt 1):1308-12.
1991: James E Haddow; George J Knight; E M Kloza; Glenn E Palomaki; Nicholas J Wald
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery.
British journal of obstetrics and gynaecology 1991;98(9):859-65.
1991: RZ Klein; James E Haddow; JD Faix; R S Brown; Rosalie J Hermos; A Pulkkinen; Marvin L Mitchell
Prevalence of thyroid deficiency in pregnant women.
Clinical endocrinology 1991;35(1):41-6.
1990: James E Haddow
Prenatal screening for open neural tube defects, Down's syndrome, and other major fetal disorders.
Seminars in perinatology 1990;14(6):488-503.
1990: B A Chilmonczyk; George J Knight; Glenn E Palomaki; A J Pulkkinen; J Williams; James E Haddow
Environmental tobacco smoke exposure during infancy.
American journal of public health 1990;80(10):1205-8.
1990: A M Johnson; Glenn E Palomaki; James E Haddow
The effect of adjusting maternal serum alpha-fetoprotein levels for maternal weight in pregnancies with fetal open spina bifida. A United States collaborative study.
American journal of obstetrics and gynecology 1990;163(1 Pt 1):9-11.
1990: Wendy Y Craig; Glenn E Palomaki; A M Johnson; James E Haddow
Cigarette smoking-associated changes in blood lipid and lipoprotein levels in the 8- to 19-year-old age group: a meta-analysis.
Pediatrics 1990;85(2):155-8.
1990: A M Johnson; Glenn E Palomaki; James E Haddow
Maternal serum alpha-fetoprotein levels in pregnancies among black and white women with fetal open spina bifida: a United States collaborative study.
American journal of obstetrics and gynecology 1990;162(2):328-31.
1990: Glenn E Palomaki; George J Knight; M S Holman; James E Haddow
Maternal serum alpha-fetoprotein screening for fetal Down syndrome in the United States: results of a survey.
American journal of obstetrics and gynecology 1990;162(2):317-21.
1989: C Goldfine; James E Haddow; George J Knight; Glenn E Palomaki
Amniotic fluid alpha-fetoprotein and acetylcholinesterase measurements in pregnancies associated with gastroschisis.
Prenatal diagnosis 1989;9(10):697-700.
1989: George J Knight; Glenn E Palomaki; D H Lea; James E Haddow
Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay.
Clinical chemistry 1989;35(6):1036-9.
1989: Wendy Y Craig; Glenn E Palomaki; James E Haddow
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data.
BMJ (Clinical research ed.) 1989;298(6676):784-8.
1989: C Goldfine; George J Knight; James E Haddow; Glenn E Palomaki
Amniotic fluid acetylcholinesterase measurements: comparing immunochemical and polyacrylamide gel techniques.
Prenatal diagnosis 1989;9(3):167-72.
1988: James E Haddow; George J Knight; Glenn E Palomaki; J E McCarthy
Second-trimester serum cotinine levels in nonsmokers in relation to birth weight.
American journal of obstetrics and gynecology 1988;159(2):481-4.
1988: George J Knight; Glenn E Palomaki; James E Haddow
Use of maternal serum alpha-fetoprotein measurements to screen for Down's syndrome.
Clinical obstetrics and gynecology 1988;31(2):306-27.
1988: Glenn E Palomaki; L E Hill; George J Knight; James E Haddow; M Carpenter
Second-trimester maternal serum alpha-fetoprotein levels in pregnancies associated with gastroschisis and omphalocele.
Obstetrics and gynecology 1988;71(6 Pt 1):906-9.
1987: James E Haddow; George J Knight; Glenn E Palomaki; E M Kloza; Nicholas J Wald
Cigarette consumption and serum cotinine in relation to birthweight.
British journal of obstetrics and gynaecology 1987;94(7):678-81.
1987: James E Haddow; L E Hill; Glenn E Palomaki; George J Knight
Very low versus undetectable maternal serum alpha-fetoprotein values and fetal death.
Prenatal diagnosis 1987;7(6):401-6.
1986: James E Haddow; George J Knight; E M Kloza; Glenn E Palomaki
Alpha-fetoprotein, vaginal bleeding and pregnancy risk.
British journal of obstetrics and gynaecology 1986;93(6):589-93.
1985: Glenn E Palomaki; George J Knight; E M Kloza; James E Haddow
Maternal weight adjustment and low serum alpha-fetoprotein values.
Lancet 1985;1(8426):468.
1985: George J Knight; P Wylie; M S Holman; James E Haddow
Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies.
Clinical chemistry 1985;31(1):118-21.
1984: James E Haddow; Glenn E Palomaki; E M Kloza; George J Knight
Does smoking influence serum alpha-fetoprotein levels in mid-trimester pregnancies?
British journal of obstetrics and gynaecology 1984;91(12):1188-91.
1984: James E Haddow; George J Knight; A J Pulkkinen; D E Smith
The relationship between serum beta 1-glycoprotein and alpha-fetoprotein levels in the second trimester and birth weight.
American journal of obstetrics and gynecology 1984;148(1):108-9.
1983: James E Haddow; E M Kloza; D E Smith; George J Knight
Data from an alpha-fetoprotein pilot screening program in Maine.
Obstetrics and gynecology 1983;62(5):556-60.
1982: James E Haddow; George J Knight; E M Kloza
Alpha-fetoprotein screening in pregnancy-a test whose time has come.
Arizona medicine 1982;39(7):436-9.
1982: George J Knight; A J Pulkkinen; James E Haddow
Levels of C-peptide in second-trimester amniotic fluid.
American journal of obstetrics and gynecology 1982;142(8):1062-3.
1981: George J Knight; E M Kloza; D E Smith; James E Haddow
Efficiency of human placental lactogen and alpha-fetoprotein measurement in twin pregnancy detection.
American journal of obstetrics and gynecology 1981;141(5):585-6.
1981: James E Haddow; E M Kloza; George J Knight; D E Smith
Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester.
Clinical chemistry 1981;27(1):133-4.
1980: M S Holman; George J Knight; James E Haddow
Acetylthiocholine iodide for detecting acetylcholinesterase activity in amniotic fluid.
Lancet 1980;2(8195 pt 1):651.